CSRxP STATEMENT ON THE PASSING OF DAVID MITCHELL
Jan 5, 2026
Founder and President of Patients for Affordable Drugs Was a Tireless and… Read More
© 2026 CSRXP- All Rights Reserved
Press & Statements
CSRxP: BIG PHARMA RINGS IN 2026 WITH MORE THAN 300 PRICE INCREASES ON BRAND NAME DRUGS, OUTPACING START OF 2025
Jan 5, 2026
Big Pharma Giants Including Pfizer and GSK Kickoff a New Year with Price Hikes… Read More
CSRxP APPLAUDS U.S. HOUSE PASSAGE OF Q1/Q2 REFORMS TO FOSTER GREATER COMPETITION IN THE PRESCRIPTION DRUG MARKETPLACE
Dec 2, 2025
Bipartisan, Market-Based Solution Would Increase Transparency… Read More
CSRxP APPLAUDS ADMINISTRATION FOR COMMITMENT TO FOSTERING GREATER BIOSIMILAR COMPETITION, LOWERING DRUG PRICES FOR AMERICAN PATIENTS
Oct 29, 2025
Efforts to Eliminate Red Tape and Boost Access to More Affordable Alternatives… Read More
CSRxP: HELP COMMITTEE SHOULD REJECT BIG PHARMA’S DEBUNKED INNOVATION RHETORIC, FOCUS ON IMPROVING COMPETITION TO HIGH-PRICED BIOLOGIC BLOCKBUSTERS
Oct 28, 2025
Lawmakers Can Add to Bipartisan Momentum for Market-Based Solutions to Foster… Read More
CBO NEARLY DOUBLES COST ANALYSIS FOR BIG PHARMA’S BLOCKBUSTER BAILOUT, FINDING SENIORS AND TAXPAYERS WILL PAY $8.8 BILLION DUE TO HIGHER DRUG PRICES
Oct 20, 2025
Armed with More Accurate Information on the True Impact of Pharma-Backed… Read More
CSRxP: PERA WOULD FURTHER ENABLE BIG PHARMA’S PATENT ABUSE THAT KEEPS PRESCRIPTION DRUG PRICES HIGH
Oct 7, 2025
Senate Judiciary Lawmakers Should Reject Big Pharma-Backed Proposal and… Read More
U.S. HOUSE COMMITTEE SHOULD ADVANCE Q1/Q2 REFORMS TO PROMOTE GREATER COMPETITION AND HELP LOWER PRESCRIPTION DRUG PRICES
Sep 17, 2025
Lawmakers Should Advance Bipartisan, Market-Based Solution to Crack Down on… Read More
CSRxP ENCOURAGES HELP COMMITTEE TO HIGHLIGHT BIG PHARMA’S EGREGIOUS PRICING AND ANTI-COMPETITIVE PRACTICES IN HEARING ON HEALTH CARE AFFORDABILITY
Jul 30, 2025
Lawmakers Can Build on Track Record of Bipartisan Collaboration by Advancing… Read More
CSRxP STATEMENT ON U.S. SENATE REINTRODUCTION OF THE ETHIC ACT
Jul 16, 2025
Coalition Commends Bipartisan Group of Lawmakers for Commitment to Cracking… Read More
CSRxP STATEMENT ON BIG PHARMA GIVEAWAY IN RECONCILIATION BILL TEXT
Jun 28, 2025
Pharma-Backed Policy Would Cost Seniors and Taxpayers Billions of Dollars in… Read More
CSRxP APPLAUDS U.S. SENATE REINTRODUCTION OF BIPARTISAN SOLUTION TO PROMOTE GREATER BIOSIMILAR COMPETITION IN THE PRESCRIPTION DRUG MARKET
Jun 6, 2025
Legislation Would Remove Regulatory Barriers to Foster Greater Competition… Read More